P/N 11108941 MBT-CA System, 1EA
This system is compatible with the Bruker CA MALDI Mass Spectrometer currently used to support MRSN's mission of conducting epidemiological surveillance of multi-drug resistant organisms (MDROs) to enhance performance improvement and infection control across the Department of Defense (DoD). Purchase of the new system will support expansion of services with increased workload and will support current technology, as well as, the College of American Pathologist (CAP) accreditation process.
The North American Industry Classification System (NAICS) for this requirement is 334516 and the size standard is 1000 employees.
This announcement constitutes the only notice by the government; a written solicitation will not be issued. All sources that believe they are eligible to provide these items must respond in writing. Responses must be supported with clear and convincing evidence to clearly articulate the ability to provide the items outlined above. A request for documentation will not be considered an affirmative response. This Special Notice of Intent is not a request for competitive quotes. Information received will be considered solely for the purpose of determining whether a competitive procurement is in the best interest of the Government. If no written responses are received by the date listed below, the purchase will be awarded without further remark. All questions and responses concerning this notice shall be emailed to Ms. Dawn Jennings at [email protected].
Interested concerns must identify their capability in writing to the above e-mail address or by mail to the address listed below no later than 12:00 pm EST, Thursday, September 22, 2016.
Contracting Office Address:
US Army Medical Research Acquisition Activity, ATTN: MCMR-AAA, 820 Chandler Street, Frederick, MD 21702-5014
Point of Contact:
Dawn Jennings